Closing the Gap to Care: Assessing CAD and Improving Patient Outcomes with Revascularization
Closing the Gap to Care: Assessing CAD and Improving Patient Outcomes with Revascularization
Talking Rare: Epidemiology and Pathogenesis of APOL1-Mediated Kidney Disease
Talking Rare: Epidemiology and Pathogenesis of APOL1-Mediated Kidney Disease
Optimizing Bone Health in Postmenopausal Post-Fracture Patients
Optimizing Bone Health in Postmenopausal Post-Fracture Patients
Preoperative Concerns Regarding Neoadjuvant Therapy and Delays in Surgery
Preoperative Concerns Regarding Neoadjuvant Therapy and Delays in Surgery
Who Is Eligible for Neoadjuvant or Adjuvant Immunotherapy?
Who Is Eligible for Neoadjuvant or Adjuvant Immunotherapy?
Lack of Concordance Between Radiologic and Pathologic Responses in Neoadjuvant ICI Treatment of Melanoma: How Do I Assess Radiologic Progression?
Lack of Concordance Between Radiologic and Pathologic Responses in Neoadjuvant ICI Treatment of Melanoma: How Do I Assess Radiologic Progression?
What Are the Data Supporting Neoadjuvant Therapy in Melanoma?
What Are the Data Supporting Neoadjuvant Therapy in Melanoma?
Panel: Preserving Operability: How To Manage irAEs in the Perioperative Setting During Neoadjuvant Treatment of Melanoma?
Panel: Preserving Operability: How To Manage irAEs in the Perioperative Setting During Neoadjuvant Treatment of Melanoma?
Panel: Discussing Neoadjuvant/Adjuvant ICI-Based Therapy With Patients and Caregivers
Panel: Discussing Neoadjuvant/Adjuvant ICI-Based Therapy With Patients and Caregivers
Panel: Critical Considerations in the Use of ICIs in High-Risk Resectable Melanomas
Panel: Critical Considerations in the Use of ICIs in High-Risk Resectable Melanomas
Should a Patient With a BRAF-Mutated Tumor Receive Targeted vs ICI Neoadjuvant Therapy?
Should a Patient With a BRAF-Mutated Tumor Receive Targeted vs ICI Neoadjuvant Therapy?
Panel: How and When Should I Assess Response to Neoadjuvant and Adjuvant ICI Therapy?
Panel: How and When Should I Assess Response to Neoadjuvant and Adjuvant ICI Therapy?
What Are the Data Supporting Adjuvant Therapy in Melanoma?
What Are the Data Supporting Adjuvant Therapy in Melanoma?
What Is the Rationale for Neoadjuvant and Adjuvant Therapy in Melanoma?
What Is the Rationale for Neoadjuvant and Adjuvant Therapy in Melanoma?